HK1085725A1 - Pyridyloxymethyl and benzisoxazole azabicyclic derivatives - Google Patents
Pyridyloxymethyl and benzisoxazole azabicyclic derivativesInfo
- Publication number
- HK1085725A1 HK1085725A1 HK06105638.1A HK06105638A HK1085725A1 HK 1085725 A1 HK1085725 A1 HK 1085725A1 HK 06105638 A HK06105638 A HK 06105638A HK 1085725 A1 HK1085725 A1 HK 1085725A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridyloxymethyl
- benzisoxazole
- azabicyclic derivatives
- benzisoxazole azabicyclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45392503P | 2003-03-12 | 2003-03-12 | |
| PCT/IB2004/000499 WO2004081007A1 (fr) | 2003-03-12 | 2004-02-23 | Derives azabicycliques de pyridyloxymethyl et de benzisoxazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1085725A1 true HK1085725A1 (en) | 2006-09-01 |
Family
ID=32990837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06105638.1A HK1085725A1 (en) | 2003-03-12 | 2006-05-16 | Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7345038B2 (fr) |
| EP (1) | EP1608648B1 (fr) |
| JP (2) | JP3910627B2 (fr) |
| KR (2) | KR100767854B1 (fr) |
| CN (1) | CN100389115C (fr) |
| AP (1) | AP2005003390A0 (fr) |
| AR (1) | AR043537A1 (fr) |
| AU (2) | AU2004220327B2 (fr) |
| BR (1) | BRPI0408248A (fr) |
| CA (1) | CA2518740C (fr) |
| EA (1) | EA009527B1 (fr) |
| EC (1) | ECSP056011A (fr) |
| GT (1) | GT200400041A (fr) |
| HK (1) | HK1085725A1 (fr) |
| HR (1) | HRP20050798A2 (fr) |
| IL (1) | IL170290A (fr) |
| MA (1) | MA27747A1 (fr) |
| MX (1) | MXPA05009660A (fr) |
| NL (1) | NL1025710C2 (fr) |
| NO (1) | NO20054095L (fr) |
| OA (1) | OA13038A (fr) |
| PA (1) | PA8597501A1 (fr) |
| PE (1) | PE20041057A1 (fr) |
| PL (1) | PL378749A1 (fr) |
| RS (1) | RS20050692A (fr) |
| TN (1) | TNSN05224A1 (fr) |
| TW (1) | TW200502234A (fr) |
| UA (1) | UA78437C2 (fr) |
| UY (1) | UY28225A1 (fr) |
| WO (1) | WO2004081007A1 (fr) |
| ZA (1) | ZA200506373B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6994726B2 (en) * | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
| ATE525377T1 (de) * | 2003-10-15 | 2011-10-15 | Osi Pharm Inc | Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase |
| CA2555172A1 (fr) * | 2004-01-29 | 2005-09-09 | Pfizer Products Inc. | Combinaisons d'un antipsychotique atypique et de derives azabicycliques d'aminomethylpyridyloxy- methyle/benzisoxazole pour le traitement de troubles du systeme nerveux central |
| AP2139A (en) | 2004-04-02 | 2010-08-21 | Osi Pharm Inc | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors. |
| AR053090A1 (es) | 2004-07-20 | 2007-04-25 | Osi Pharm Inc | Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos |
| WO2006027692A2 (fr) * | 2004-09-10 | 2006-03-16 | Pfizer Products Inc. | Methodes destinees a traiter des troubles cognitifs au moyen de derives azabicycliques de pyridyloxymethyle et de benzisoxazole |
| US8575164B2 (en) * | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
| WO2009091939A1 (fr) * | 2008-01-18 | 2009-07-23 | Osi Pharmaceuticals, Inc. | Dérivés d'imidazopyrazinol pour le traitement des cancers |
| WO2009143051A1 (fr) * | 2008-05-19 | 2009-11-26 | Osi Pharmaceuticals, Inc. | Imidazopyrazines et imidazotriazines substituées |
| BRPI1016245A2 (pt) | 2009-04-20 | 2015-09-01 | Osi Pharmaceuticals Llc | Preparação de c-pirazina-metilaminas. |
| WO2010129740A1 (fr) * | 2009-05-07 | 2010-11-11 | Osi Pharmaceuticals, Inc. | Utilisation d'osi-906 dans le traitement du carcinome adrénocortical |
| WO2012052540A1 (fr) * | 2010-10-21 | 2012-04-26 | Universitaet Des Saarlandes | Inhibiteurs sélectifs de cyp11b1 pour le traitement de maladies dépendantes du cortisol |
| WO2014078568A1 (fr) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Méthodes et compositions pour le traitement de la schizophrénie |
| WO2016115282A1 (fr) * | 2015-01-13 | 2016-07-21 | Vanderbilt University | Composés à substituants benzisoxazole en tant que potentialisateurs allostériques de mglur4, compositions, et méthodes de traitement de dysfonctionnements neurologiques |
| US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
| WO2020183011A1 (fr) | 2019-03-14 | 2020-09-17 | Institut Curie | Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer |
| WO2023083445A1 (fr) | 2021-11-10 | 2023-05-19 | Symrise Ag | Compositions comprenant des agents de refroidissement agonistes de trpm8 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990008148A1 (fr) | 1989-01-23 | 1990-07-26 | Pfizer Inc. | Agents anxiolytiques bis-aza-bicycliques |
| US5167034A (en) * | 1990-06-18 | 1992-11-24 | International Business Machines Corporation | Data integrity for compaction devices |
| US5157034A (en) | 1991-02-27 | 1992-10-20 | Pfizer Inc. | Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines |
| HUT71488A (en) | 1991-09-25 | 1995-11-28 | Pfizer | Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same |
| DK0646116T3 (da) | 1992-06-16 | 1999-12-27 | Pfizer | Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler |
| US5731307A (en) | 1994-09-30 | 1998-03-24 | Pfizer, Inc. | Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines |
| BR9809697A (pt) | 1997-05-30 | 2000-07-11 | Neurosearch As | Composto, uso, e processo para a preparação do mesmo, composição farmacêutica, e, processo para tratar uma doença de um corpo de animal vivo, incluindo um humano |
| PA8469101A1 (es) * | 1998-04-09 | 2000-09-29 | Pfizer Prod Inc | Ligandos azabiciclicos de receptores 5ht1 |
| HUP0104766A3 (en) | 1998-08-26 | 2002-08-28 | Aventis Pharma Ltd West Mallin | Aza-bicycles which modulate the inhibition of cell adhesion and medicaments containing them |
| KR20010085824A (ko) | 1998-09-18 | 2001-09-07 | 스타르크, 카르크 | 단백질 키나아제 억제제로서의 피롤로피리미딘 |
| KR20010085822A (ko) | 1998-09-18 | 2001-09-07 | 스타르크, 카르크 | 키나제 억제제로서의 4-아미노피롤로피리미딘 |
| UA62015C2 (en) * | 1998-12-28 | 2003-12-15 | Pfizer Prod Inc | Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants) |
| ATE278674T1 (de) | 1999-03-12 | 2004-10-15 | Boehringer Ingelheim Pharma | Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel |
| EP1177792A3 (fr) * | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Ligands dopamine d4 destines au traitement des troubles associees a la cherche de la nouveaute |
-
2004
- 2004-02-23 OA OA1200500259A patent/OA13038A/en unknown
- 2004-02-23 WO PCT/IB2004/000499 patent/WO2004081007A1/fr active Application Filing
- 2004-02-23 JP JP2006506261A patent/JP3910627B2/ja not_active Expired - Fee Related
- 2004-02-23 UA UAA200508639A patent/UA78437C2/uk unknown
- 2004-02-23 KR KR1020057016859A patent/KR100767854B1/ko not_active IP Right Cessation
- 2004-02-23 EA EA200501148A patent/EA009527B1/ru not_active IP Right Cessation
- 2004-02-23 EP EP04713592A patent/EP1608648B1/fr not_active Expired - Lifetime
- 2004-02-23 RS YUP-2005/0692A patent/RS20050692A/sr unknown
- 2004-02-23 PL PL378749A patent/PL378749A1/pl not_active Application Discontinuation
- 2004-02-23 MX MXPA05009660A patent/MXPA05009660A/es active IP Right Grant
- 2004-02-23 AU AU2004220327A patent/AU2004220327B2/en not_active Ceased
- 2004-02-23 KR KR1020077013527A patent/KR20070074667A/ko not_active Application Discontinuation
- 2004-02-23 BR BRPI0408248-6A patent/BRPI0408248A/pt not_active IP Right Cessation
- 2004-02-23 CA CA2518740A patent/CA2518740C/fr not_active Expired - Fee Related
- 2004-02-23 CN CNB2004800066516A patent/CN100389115C/zh not_active Expired - Fee Related
- 2004-02-23 AP AP2005003390A patent/AP2005003390A0/xx unknown
- 2004-03-08 PA PA20048597501A patent/PA8597501A1/es unknown
- 2004-03-09 PE PE2004000256A patent/PE20041057A1/es not_active Application Discontinuation
- 2004-03-10 AR ARP040100770A patent/AR043537A1/es not_active Application Discontinuation
- 2004-03-11 GT GT200400041A patent/GT200400041A/es unknown
- 2004-03-11 TW TW093106481A patent/TW200502234A/zh unknown
- 2004-03-11 UY UY28225A patent/UY28225A1/es not_active Application Discontinuation
- 2004-03-12 US US10/800,328 patent/US7345038B2/en not_active Expired - Fee Related
- 2004-03-12 NL NL1025710A patent/NL1025710C2/nl not_active IP Right Cessation
-
2005
- 2005-08-10 ZA ZA200506373A patent/ZA200506373B/en unknown
- 2005-08-15 IL IL170290A patent/IL170290A/en not_active IP Right Cessation
- 2005-09-02 NO NO20054095A patent/NO20054095L/no unknown
- 2005-09-12 HR HR20050798A patent/HRP20050798A2/hr not_active Application Discontinuation
- 2005-09-12 MA MA28495A patent/MA27747A1/fr unknown
- 2005-09-12 TN TNP2005000224A patent/TNSN05224A1/fr unknown
- 2005-09-12 EC EC2005006011A patent/ECSP056011A/es unknown
-
2006
- 2006-05-16 HK HK06105638.1A patent/HK1085725A1/xx not_active IP Right Cessation
- 2006-10-26 JP JP2006291545A patent/JP2007051155A/ja active Pending
-
2010
- 2010-07-23 AU AU2010203303A patent/AU2010203303A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1085725A1 (en) | Pyridyloxymethyl and benzisoxazole azabicyclic derivatives | |
| IL241211B (en) | History of itansinoid and pharmaceutical preparations containing them | |
| AP2089A (en) | Compositions and methods for combination antiviraltherapy | |
| IL191554A0 (en) | Lactam compounds and methods of using the same | |
| IL178899A0 (en) | [3.2.0] heterocyclic compounds and methods of using the same | |
| IL174445A0 (en) | Substituted isoquinolinone derivatives and pharmaceutical compositions containing the same | |
| EP1638977A4 (fr) | Salinosporamides et leurs methodes d'utilisation | |
| EP1646318A4 (fr) | Verrous de lignes reglables et procedes associes | |
| IL174512A0 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
| HK1137439A1 (en) | Fused pyrrolocarbazoles and methods for the preparation thereof | |
| IL172704A0 (en) | Salinosporamides and methods for use thereof | |
| EP1646388A4 (fr) | Indeno et isoindoloisoquinolones cytotoxiques | |
| GB2411378B (en) | Droplet-deposition related methods and appparatus | |
| EP1646284A4 (fr) | Derives d'azole et procedes de fabrication associes | |
| ZA200804872B (en) | Lactam compounds and methods of using the same | |
| PL1670762T3 (pl) | Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące | |
| ZA200605668B (en) | Fused pyrrolocarbazoles and methods for the preparation thereof | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| EP1487799A4 (fr) | Derives de 9-aminoacridine et procede de preparation | |
| ZA200609778B (en) | [3.2.0.] Heterocyclic compounds and methods of using the same | |
| HK1169120A1 (zh) | 孢菌酰胺及其使用方法 | |
| PT2441767E (pt) | Salinosporamidas e seus métodos de utilização | |
| GB0301575D0 (en) | Tropane derivatives useful in therapy | |
| AU2999P (en) | Supalight Argyranthemum frutescens | |
| GB0326870D0 (en) | Therapeutic methods and compositions for use therein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130223 |